What Should Be the Best Output of Healthcare? Reflections Based on Value-Based Healthcare Theory
DOI:
https://doi.org/10.54097/pspv4d51Keywords:
Value-Based Healthcare; Patient-Reported Outcome Measures; Payment Reform; Cost-Effectiveness; China Healthcare Reform.Abstract
The traditional measure of a health care system success is based on the number of care provided, such as hospital visits, procedures, or tests. Although these are low-hanging fruits, they are actually deceptive because they reward activities without measuring whether they make people healthier. This leads to waste, inefficiency and intervention measures that provide little benefit to patients. Value-based health care (VBHC) is a more pragmatic model that defines output as the results that patients actual value relative to the costs. This article discusses the main ideas of VBHC and why it is a superior basis for evaluating health care. It pays special attention to two basic tools: the Patient-Reported Outcome Measure (PROM) to evaluate the patient's own experience, and payment innovation, such as bundled or outcome-based models, which link financial incentives with actual improvement. In order to understand how these ideas work in the real world, this article discusses examples from ophthalmology, in which outcome data and cost-effectiveness analysis guide the deployment of traditional care and new technologies. The study also considers the advantages of VBHC, including greater patient-centeredness and higher efficiency, and the disadvantages, including the lack of high-quality data to support and hardship to ensure the fairness among different patient groups. Finally, the study discusses the situation in China, where VBHC can help cope with growing demand with limited resources. Overall, this article argues that the actual output of health care is not the amount of services provided, but the real value added to the patient's life.
Downloads
References
[1] De Mattia E., Angioletti C., D’Agostino M., Paoletti F., De Belvis A. G. Moving from principles to practice: A scoping review of value-based healthcare (VBHC) implementation strategies. Healthcare (Basel), 2024, 12(23): 2457.
[2] Organization for Economic Co-operation and Development. Tackling wasteful spending on health. OECD Publishing (Paris), 2017.
[3] Smith P. C., Sagan A., Siciliani L., Figueras J. Building on value-based health care: Towards a health system perspective. Health Policy, 2023, 138: 104918.
[4] Kidanemariam M., Neve O. M., van den Heuvel I., Douz S., Hensen E. F., Stiggelbout A. M., Pieterse A. H. Patient-reported outcome measures in value-based healthcare: A multiple methods study to assess patient-centredness. Patient Education and Counseling, 2024, 125: 108243.
[5] Crane E., Noyes J., Bianchim M. S., McLaughlin L., Cahill A., Roberts G., Stringer C. A social return on investment of PROM implementation in value-based healthcare. Journal of Patient-Reported Outcomes, 2025, 9: 22.
[6] Smith P. C., Sagan A., Siciliani L., Figueras J. Value-based health care in theory and practice. JAMA Health Forum, 2022, 3(6): e221557.
[7] Van Engen V. Enhancing patient response to patient-reported outcome measures: Insights from a leading Dutch university hospital. Value in Health, 2024, 27(12): 1753–1761.
[8] Leao D. L. L., Moers L. A. M., Cremers H.-P., van Veghel D., Groot W., Pavlova M. Design, implementation and evaluation of value-based payment models: A Delphi study. BMC Health Services Research, 2025, 25(1): 116.
[9] Purohit N. Optimizing diabetic retinopathy screening at primary health centres in India: A cost-effectiveness analysis. Health and Quality of Life Outcomes, 2025, 12209073.
[10] Liu Z. Cost-effectiveness of incorporating self-imaging optical coherence tomography into fundus photography-based diabetic retinopathy screening. npj Digital Medicine, 2024, 7: 225.
[11] Wu H., Jin K., Yip C. C., Koh V., Ye J. A systematic review of economic evaluation of artificial intelligence–based screening for eye diseases: from possibility to reality. Survey of Ophthalmology, 2024, 69(4): 499–507.
[12] Hu W. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: A cost-effectiveness analysis. eClinicalMedicine, 2024, 67: 102387.
[13] Etges A. P. B. de Silva, Liu H. H., Jones P., Polanczyk C. A. Value-based reimbursement as a mechanism to achieve social and financial impact in the healthcare system. Journal of Health Economics and Outcomes Research, 2023, 10(2): 100–103.
[14] Tao W. Towards universal health coverage: Achievements and challenges of 10 years of healthcare reform in China. BMJ Global Health, 2020, 5(3): e002087.
[15] World Health Organization. Healthy China. Ninth Global Conference on Health Promotion, 2016, 1–6.
[16] Chen Y., He Y., Chi X., Wei Y., Shi L. Development of health technology assessment in China: New challenges. BioScience Trends, 2018, 12(2): 102–108.
[17] Zhao M. Effects of pay-for-performance for primary care physicians on type 2 diabetes outcomes: Evidence from rural China. Diabetes Research and Clinical Practice, 2025, 112046.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Highlights in Business, Economics and Management

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







